Primary Antibodies

Immunogen chromosome 1 open reading frame 194 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization

Immunogen C1q and tumor necrosis factor related protein 5 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive

Immunogen C20orf132 (AAH57767.1, 1 a.

Immunogen chromosome 20 open reading frame 194 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive

Immunogen chromosome 20 open reading frame 24 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization

Immunogen chromosome 2 open reading frame 50 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization

Immunogen chromosome 2 open reading frame 68 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization

Immunogen chromosome 2 open reading frame 73 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization

Immunogen carbonic anhydrase X Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the

General description Anti-CA181 Antibody detects endogenous levels of total CA181 protein. Immunogen The antiserum was produced against synthesized peptide derived from human CA181.

Immunogen calcium channel, voltage-dependent, beta 2 subunit recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and

Immunogen Peptide with sequence C-DYPDSYQDTYKPH from the internal region (near the C Terminus) of the protein sequence according to NP_001005747.1: NP_000717.